PGY2 Infectious Diseases Pharmacy Residency Program
The UTMB Health PGY2 Infectious Diseases pharmacy residency program is designed to prepare PGY1 pharmacy residency graduates for a career focused in the care of patients with infectious diseases. Residents will have the opportunity to develop knowledge and skills in infectious diseases and clinical microbiology. The PGY2 resident will work closely with the Adult Infectious Diseases Consult Service and other clinical services.
The resident will also be a member of the health system’s Antimicrobial Stewardship Committee and have the opportunity to learn, establish, and perform evidence-based antimicrobial stewardship strategies to optimize antibiotic use throughout the institution.
The resident will expand his/her teaching skills by interacting with students from four area colleges of pharmacy. Residency projects are presented as posters at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition and as a platform presentation at Alcáldé, a regional residency conference.
The PGY2 Infectious Diseases pharmacy residency program is currently in candidate status by the (ASHP). The program code is 74127.
For further information, contact:
R. Scott Ferren, Pharm.D., BCIDP
PGY2 Infectious Diseases Pharmacy Residency Program Director
Email: rsferren@utmb.edu
UTMB Health Department of Pharmacy
ASHP Pre-candidate Status PGY2 - Infectious Disease Pharmacy Residency
- Providing safe and effective patient care to a diverse range of patients in collaboration with the health care team
- Establish and perform evidence-based antimicrobial stewardship strategies
- Exercising leadership and management skills
- Provide teaching, education, and dissemination of knowledge
Program Structure 2020-2021*
The purpose of this structure is to comply with the PGY2 program purpose: PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
First month of the residency (July)
-Residency Project Selection
-On-line Training
-Inpatient
Pharmacy
-IV Room
-Epic EMR
-Pyxis
-Bugs and
Drugs
-ID
Guideline Review
-Policy Review
-Staffing Competencies
-Infectious Diseases Consult Service – 2 blocks (4 weeks each)
-Antimicrobial Stewardship – 2 blocks (5 weeks each)
-Microbiology (3 weeks)
-Infectious Diseases Internal Medicine (4 weeks)
HIV primary team
-Neonatal/Pediatric Infectious Diseases (4 weeks)
-Transplant ID Consult (4 weeks)
-Community Hospital ID Consult (4 weeks)
2 Rotations
-Intensive Care Unit (4 weeks)
Medical or Surgical
-Solid Organ Transplant (4 weeks)
-Emergency Medicine (4 weeks)
-Hematology/Oncology (4 weeks)
Early Commitment Resident Orientation
Residency Project Selection
On-line Training
ID Guideline Review
Policy Review
Longitudinal Practice Experiences
ID
outpatient (January-June)
Residency
Project (July-June)
Medication
Use Evaluation (approximately 6 months)
All longitudinal practice experiences occur between July and June of the residency year